Norbrook, Boehringer End Dog Drug IP Brawl

Law360, New York (November 18, 2009, 1:02 PM EST) -- Boehringer Ingelheim Pharma GmbH & Co. KG has settled a suit it filed against Norbrook Laboratories Ltd. claiming the veterinary pharmaceutical company infringed a patent for Metacam when seeking approval for a generic version of the canine anti-inflammatory.

Judge Greg Kays of the U.S. District Court for the Western District of Missouri dismissed the case without prejudice on Tuesday, after Boehringer and Norbrook said the suit had been settled.

The settlement dismisses Germany-based Boehringer's claims and Norbrook's counterclaims, with each party paying its own costs and...
To view the full article, register now.